Thursday 9 February 2017

Updated ACIP Immunization Schedule for Adults

Updated ACIP Immunization Schedule for Adults The Advisory Committee on Immunization Practices (ACIP) has released updated immunization schedule for adults aged 19 years or older, United States, which have been published February 7, 2017 in the Annals of Internal Medicine. • ACIP recommends against live attenuated influenza vaccine (LAIV) during the 2016–2017 influenza season. • Adults with a history of egg allergy who have only hives after exposure to egg should receive age-appropriate inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV). • Healthy adolescents who start their human papillomavirus vaccine (HPV) series before age 15 years are recommended to receive 2 doses of HPV. But, for adults and adolescents who did not start their vaccination series before age 15 years, 3 doses are recommended. • Hepatitis B vaccine is recommended for adults with chronic liver disease, including, but not limited to, hepatitis C virus infection, cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, and an alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level greater than twice the upper limit of normal. • A 2-dose primary series of serogroups A, C, W, and Y meningococcal conjugate vaccine is recommended for adults with HIV infection. • Three doses of MenB-FHbp are recommended for adults at increased risk for meningococcal disease and for use during serogroup B meningococcal disease outbreaks, while 2 doses have been recommended for healthy adolescents and young adults who are not at increased risk for meningococcal disease. (Source: Ann Intern Med. 2017;166(3):209-219)

No comments:

Post a Comment